OOIR: Observatory of International Research

Papers

(The median citation count of Seminars in Immunopathology is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)

Article	Citations
Complement & disease: out of the shadow into the spotlight	106
Fine mapping with epigenetic information and 3D structure	88
CAF-immune cell crosstalk and its impact in immunotherapy	83
Thymus and autoimmunity	83
Harnessing the n+1 dimensions of single-cell omics data for the prediction and prevention of human diseases	78
Halting targeted and collateral damage to red blood cells by the complement system	77
Learning cell identity in immunology, neuroscience, and cancer	74
Systemic innate myeloid responses to acute ischaemic and haemorrhagic stroke	73
Proteomics to study cancer immunity and improve treatment	59
The fetal programming effect of maternal immune activation (MIA) on the offspring’s immune system	59
Causes and costs of global COVID-19 vaccine inequity	56
Vascular galectins in tumor angiogenesis and cancer immunity	53
Monocyte dysregulation: consequences for hepatic infections	47
Disease pathogenesis and barrier functions regulated by group 3 innate lymphoid cells	42
Single-cell high-dimensional imaging mass cytometry: one step beyond in oncology	42
Th17 cells in the liver: balancing autoimmunity and pathogen defense	41
The eosinophil and its role in physiology and disease: news and views	38
Neuroimaging is the new “spatial omic”: multi-omic approaches to neuro-inflammation and immuno-thrombosis in acute ischemic stroke	35
Circadian rhythms in adaptive immunity and vaccination	35
Development of vascular disease models to explore disease causation and pathomechanisms of rare vascular diseases	35
Adaptive immunity, chronic inflammation and the clock	34
Unveiling the gut-brain axis: structural and functional analogies between the gut and the choroid plexus vascular and immune barriers	32
Tumor microenvironment antigens	32
Novel immune cell phenotypes in spondyloarthritis pathogenesis	31
MAIT cells in liver inflammation and fibrosis	31

Clonal hematopoiesis and vascular disease	31
Cellular senescence in the cholangiopathies: a driver of immunopathology and a novel therapeutic target	31
Recent advances on the role of cytotoxic T lymphocytes in the pathogenesis of spondyloarthritis	30
Functional heterogeneity of CD4+ T cells in liver inflammation	30
Harnessing the tumor microenvironment to boost adoptive T cell therapy with engineered lymphocytes for solid tumors	29
Neuroimmune interactions in health and disease	29
The role of circulating cell-free DNA as an inflammatory mediator after stroke	29
Beyond GWAS: from simple associations to functional insights	28
Chronoimmunology: from preclinical assessments to clinical applications	28
The mucosal immune system and IgA nephropathy	27
Regulatory T lymphocytes as a therapy for ischemic stroke	27
Multiparameter single-cell proteomic technologies give new insights into the biology of ovarian tumors	27
The overlooked bacterial pandemic	26
Role of polyamines in intestinal mucosal barrier function	26
Genetics and functional genomics of multiple sclerosis	26
Revisiting transplant immunology through the lens of single-cell technologies	25
Intracellular galectin interactions in health and disease	25
Advances in manufacturing chimeric antigen receptor immune cell therapies	23
The role of circadian clock pathways in viral replication	23
Immune biology of NSCLC revealed by single-cell technologies: implications for the development of biomarkers in patients treated with immunotherapy	22
The twilight zone: plasticity and mixed ontogeny of neutrophil and eosinophil granulocyte subsets	22
Diseases of blood vessels: Immune system involvement in vasculitis and vasculopathy	21
Targeting tumour-reprogrammed myeloid cells: the new battleground in cancer immunotherapy	21
COVID-19 Vasculitis and vasculopathy-Distinct immunopathology emerging from the close juxtaposition of Type II Pneumocytes and Pulmonary Endothelial Cells	21
Metabolic Regulation in the Induction of Trained Immunity	21
Neuropathogenesis of HIV-1: insights from across the spectrum of acute through long-term treated infection	20
Combination immunotherapy with synthetic long peptides and chemotherapy or PD-1 blocker for cancers caused by human papilloma virus type 16	20
The good and the bad about separation anxiety: roles of IL-22 and IL-22BP in liver pathologies	20
The intestinal and biliary microbiome in autoimmune liver disease—current evidence and concepts	19
The contribution of sleep to the neuroendocrine regulation of rhythms in human leukocyte traffic	19
Correction to: MAIT cells in liver inflammation and fibrosis	18
Epithelial recognition and elimination against aberrant cells	18
Glycoprotein 2 as a gut gate keeper for mucosal equilibrium between inflammation and immunity	18
The aging immune system in Alzheimer’s and Parkinson’s diseases	18
Genetic overlap between type 1 diabetes and other autoimmune diseases	18
Crosstalk between the DNA damage response and cellular senescence drives aging and age-related diseases	18
Unveiling the immunopathology of stroke: a comprehensive view on brain-immune interaction	17
CAR T-cell behavior and function revealed by real-time imaging	16
Mechanisms of immunothrombosis and vasculopathy in antiphospholipid syndrome	16
Innate immunity in hepatitis B and D virus infection: consequences for viral persistence, inflammation, and T cell recognition	16
Local anesthetics and immunotherapy: a novel combination to fight cancer	16
The microbiome and IgA nephropathy	16
IgA vasculitis	15
Recent advances in understanding the genetic basis of systemic lupus erythematosus	15
Highly multiplexed spatial profiling with CODEX: bioinformatic analysis and application in human disease	15
Beyond defence: Immune architects of ovarian health and disease	15
Role of bile acids in inflammatory liver diseases	15
IgA glycosylation and immune complex formation in IgAN	15
Thymic origins of autoimmunity—lessons from inborn errors of immunity	14
Genetics and functional genetics of autoimmune diseases	14

Tissue-resident immunity in the female and male reproductive tract	14
Mechanisms of vascular damage in ANCA vasculitis	13
Correction: Glycoprotein 2 as a gut gate keeper for mucosal equilibrium between inflammation and immunity	13
Physiological and immunological barriers in the lung	13
HLA imputation and its application to genetic and molecular fine-mapping of the MHC region in autoimmune diseases	13
The role of the mucosal barrier system in maintaining gut symbiosis to prevent intestinal inflammation	13
Microbial-derived antigens and metabolites in spondyloarthritis	13
Correction to: Narcolepsy: a model interaction between immune system, nervous system, and sleep-wake regulation	13
Arginine metabolism in myeloid cells in health and disease	12
How will artificial intelligence and bioinformatics change our understanding of IgA Nephropathy in the next decade?	12
Cell therapies for viral diseases: a new frontier	12
Navigating the diverse immune landscapes of psoriatic arthritis	12
Eosinophils and eosinophil-associated disorders: immunological, clinical, and molecular complexity	12
Introduction: thymus development and function in health and disease	11
Narcolepsy: a model interaction between immune system, nervous system, and sleep-wake regulation	11
Novel immunotherapeutic combinations moving forward: the modulation of the immunosuppressive microenvironment	11
Mechanistic insights into intrauterine adhesions	11
Regulation of eosinophil functions by autophagy	11
Correction to: How will artificial intelligence and bioinformatics change our understanding of IgA Nephropathy in the next decade?	11
Heterogeneity of tissue-resident immunity across organs and in health and disease	11
Role of Hyaluronic acid and its chemical derivatives in immunity during homeostasis, cancer and tissue regeneration	10
Thromboinflammatory challenges in stroke pathophysiology	10
Immuno-pathogenesis of neuromyelitis optica and emerging therapies	10
Management of cell death in parasitic infections	10
Genetics of rheumatoid arthritis	9
Metabolic regulation and function of T helper cells in neuroinflammation	9
The aryl hydrocarbon receptor in liver inflammation	9
Aberrant antigen processing and presentation: Key pathogenic factors leading to immune activation in Ankylosing spondylitis	9
Eosinophils and helminth infection: protective or pathogenic?	9
The immunology of Parkinson’s disease	9
The role of vaccines in the COVID-19 pandemic: what have we learned?	9
Complement activation in IgA nephropathy	9
Circadian regulation of innate immunity in animals and humans and implications for human disease	9
Mediators of liver inflammation and carcinogenesis	9
The gut-joint axis in spondyloarthritis: immunological, microbial, and clinical insights	9
Lessons (to be) learned from liquid biopsies: assessment of circulating cells and cell-free DNA in cancer and pregnancy-acquired microchimerism	9